lactic acid has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 3 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, X | 1 |
| Wang, L | 1 |
| Qiu, Y | 1 |
| Zhang, B | 1 |
| Hu, Z | 1 |
| Jin, R | 1 |
| Chittasupho, C | 1 |
| Manikwar, P | 1 |
| Krise, JP | 1 |
| Siahaan, TJ | 1 |
| Berkland, C | 1 |
| Selivanov, VA | 1 |
| Vizán, P | 1 |
| Mollinedo, F | 1 |
| Fan, TW | 1 |
| Lee, PW | 1 |
| Cascante, M | 1 |
3 other studies available for lactic acid and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Drug Liberation; Drug S | 2017 |
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
Topics: Biological Transport, Active; Cell Adhesion; Cell Aggregation; Cell Line, Tumor; Drug Delivery Syste | 2010 |
Edelfosine-induced metabolic changes in cancer cells that precede the overproduction of reactive oxygen species and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Glucose; Humans; Isotopes; Jurkat Cells; Lactic Acid; Phospholipid | 2010 |